全内镜冠状动脉旁路移植术:1500例单中心经验
该单中心回顾性研究纳入2016年1月至2023年2月连续1500例接受Endo-CABG(长杆器械非机器人全内镜冠脉搭桥)的患者,随访1年。
要点
- Endo-CABG术后1年移植血管失败率为1.80%(n=27)。
- 1年无MACCE生存率为91.7%(95%CI 90.2-93.2%),年龄、LVEF、高血压和急诊状态与1年结局显著相关。
核心结论
- Endo-CABG似乎是安全的,能实现外科血运重建,并在1年移植血管失败和MACCE方面提供良好结局,同时年龄、左心室射血分数、动脉高血压和急诊状态与1年结局相关。
研究设计与样本
- 单中心回顾性研究,连续纳入1500例于2016年1月至2023年2月接受Endo-CABG的患者,随访1年。
主要发现
- 平均年龄68[61-75]岁,其中193例(12.87%)为八十岁及以上患者。
- 多支血管病变1409例(93.93%),平均EuroSCORE II为1.64[1.09-2.92]%。
- 所有患者均接受全动脉血运重建,其中88.47%使用双侧内乳动脉搭桥。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Totally endoscopic coronary artery bypass grafting (TECAB) is a minimally invasive approach to achieve surgical revascularization through a minimally invasive approach. Still, data regarding non-robotic TECAB are limited. This report presents the results of a TECAB technique using long-shafted instruments, defined as Endo-CABG, from a single-centre experience in 1500 consecutive patients. METHODS: One thousand and five hundred patients underwent Endo-CABG between January 2016 and February 2023. Data were collected retrospectively, and patients were followed up for 1 year. The primary outcome of this study was major adverse cardiac and cerebrovascular events (MACCE)-free survival. Secondary efficacy outcomes were graft failure and mortality. Furthermore, we analysed factors influencing long-term freedom from MACCE and all-cause mortality. RESULTS: The mean age was 68 [61-75] years, of which 193 (12.87%) were octogenarians. Multivessel disease was present in 1409 (93.93%) patients, and the mean EuroSCORE II was 1.64 [1.09-2.92] %. All patients underwent full arterial revascularization with bilateral internal mammary grafting in 88.47%. Graft failure occurred in 1.80% of cases after 1 year (n = 27). Thirty-day mortality was 1.73% (n = 26), 1-year survival was 94.7% (95% CI: 93.5-95.9%; n = 26) and 1-year MACCE-free survival was 91.7% (95% CI: 90.2-93.2%). Age, left ventricular ejection fraction, arterial hypertension and urgency were significantly associated with 1-year MACCE-free survival. CONCLUSIONS: Endo-CABG appears to be a safe procedure, achieves surgical revascularization and provides good outcomes regarding graft failure and MACCE at 1 year, while age, left ventricular ejection fraction, arterial hypertension and urgency were associated with 1-year outcomes.
引用
- Claessens J, Packlé L, Oosterbos H, et al. Totally endoscopic coronary artery bypass grafting: experience in 1500 patients. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39287016. doi:10.1093/icvts/ivae159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。